omim.org

Online Mendelian Inheritance in Man (OMIM)

  • ️Fri Feb 24 2023

  1. Adeokun, A. M., West, S. P., Ellis, F. R., Halsall, P. J., Hopkins, P. M., Foroughmand, A. M., Iles, D. E., Robinson, R. L., Stewart, A. D., Curran, J. L. The G1021A substitution in the RYR1 gene does not cosegregate with malignant hyperthermia susceptibility in a British pedigree. Am. J. Hum. Genet. 60: 833-341, 1997. [PubMed: 9106529]

  2. Alestrom, A., Fagerlund, T. H., Berg, K. A simple method to detect the RYR1 mutation G1021A, a cause of malignant hyperthermia susceptibility. Clin. Genet. 47: 274-275, 1995. [PubMed: 7554356] [Full Text: https://doi.org/10.1111/j.1399-0004.1995.tb04311.x]

  3. Avila, G., O'Brien, J. J., Dirksen, R. T. Excitation-contraction uncoupling by a human central core disease mutation in the ryanodine receptor. Proc. Nat. Acad. Sci. 98: 4215-4220, 2001. [PubMed: 11274444] [Full Text: https://doi.org/10.1073/pnas.071048198]

  4. Barone, V., Bertocchini, F., Bottinelli, R., Protasi, F., Allen, P. D., Armstrong, C. F., Reggiani, C., Sorrentino, V. Contractile impairment and structural alterations of skeletal muscles from knockout mice lacking type 1 and type 3 ryanodine receptors. FEBS Lett. 422: 160-164, 1998. [PubMed: 9489997] [Full Text: https://doi.org/10.1016/s0014-5793(98)00003-9]

  5. Bellinger, A. M., Reiken, S., Carlson, C., Mongillo, M., Liu, X., Rothman, L., Matecki, S., Lacampagne, A., Marks, A. R. Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. Nature Med. 15: 325-330, 2009. [PubMed: 19198614] [Full Text: https://doi.org/10.1038/nm.1916]

  6. Benkusky, N. A., Farrell, E. F., Valdivia, H. H. Ryanodine receptor channelopathies. Biochem. Biophys. Res. Commun. 322: 1280-1285, 2004. [PubMed: 15336975] [Full Text: https://doi.org/10.1016/j.bbrc.2004.08.033]

  7. Brandt, A., Schleithoff, L., Jurkat-Rott, K., Klingler, W., Baur, C., Lehmann-Horn, F. Screening of ryanodine receptor gene in 105 malignant hyperthermia families: novel mutations and concordance with the in vitro contracture test. Hum. Molec. Genet. 8: 2055-2062, 1999. [PubMed: 10484775] [Full Text: https://doi.org/10.1093/hmg/8.11.2055]

  8. Brennan, S., Garcia-Castaneda, M., Michelucci, A., Sabha, N., Malik, S., Groom, L., LaPierre, L. W., Dowling, J. J., Dirksen, R. T. Mouse model of severe recessive RYR1-related myopathy. Hum. Molec. Genet. 28: 3024-3036, 2019. [PubMed: 31107960] [Full Text: https://doi.org/10.1093/hmg/ddz105]

  9. Brown, R. L., Pollock, A. N., Couchman, K. G., Hodges, M., Hutchinson, D. O., Waaka, R., Lynch, P., McCarthy, T. V., Stowell, K. M. A novel ryanodine receptor mutation and genotype-phenotype correlation in a large malignant hyperthermia New Zealand Maori pedigree. Hum. Molec. Genet. 9: 1515-1524, 2000. [PubMed: 10888602] [Full Text: https://doi.org/10.1093/hmg/9.10.1515]

  10. Cavanna, J. S., Greenfield, A. J., Johnson, K. J., Marks, A. R., Nadal-Ginard, B., Brown, S. D. M. Establishment of the mouse chromosome 7 region with homology to the myotonic dystrophy region of human chromosome 19q. Genomics 7: 12-18, 1990. [PubMed: 1970795] [Full Text: https://doi.org/10.1016/0888-7543(90)90513-t]

  11. Chelu, M. G., Goonasekera, S. A., Durham, W. J., Tang, W., Lueck, J. D., Riehl, J., Pessah, I. N., Zhang, P., Bhattacharjee, M. B., Dirksen, R. T., Hamilton, S. L. Heat- and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse. FASEB J. 20: 329-330, 2006. [PubMed: 16284304] [Full Text: https://doi.org/10.1096/fj.05-4497fje]

  12. Cheng, H., Lederer, W. J., Cannell, M. B. Calcium sparks: elementary events underlying excitation-contraction coupling in heart muscle. Science 262: 740-744, 1993. [PubMed: 8235594] [Full Text: https://doi.org/10.1126/science.8235594]

  13. D'Arcy, C. E., Bjorksten, A., Yiu, E. M., Bankier, A., Gillies, R., McLean, C. A., Shield, L. K., Ryan, M. M. King-Denborough syndrome caused by a novel mutation in the ryanodine receptor gene. Neurology 71: 776-777, 2008. [PubMed: 18765655] [Full Text: https://doi.org/10.1212/01.wnl.0000324929.33780.2f]

  14. Deufel, T., Sudbrak, R., Feist, Y., Rubsam, B., Du Chesne, I., Schafer, K.-L., Roewer, N., Grimm, T., Lehmann-Horn, F., Hartung, E. J., Muller, C. R. Discordance, in a malignant hyperthermia pedigree, between in vitro contracture-test phenotypes and haplotypes for the MHS1 region on chromosome 19q12-13.2, comprising the C1840T transition in the RYR1 gene. Am. J. Hum. Genet. 56: 1334-1342, 1995. Note: Erratum: Am. J. Hum. Genet. 57: 520 only, 1995. [PubMed: 7762556]

  15. Dowling, J. J., Lillis S., Amburgey, K., Zhou, H., Al-Sarraj, S., Buk, S. J. A., Wraige, E., Chow, G., Abbs, S., Leber, S., Lachlan, K., Baralle, D., Taylor, A., Sewry, C., Muntoni, F., Jungbluth, H. King-Denborough syndrome with and without mutations in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromusc. Disord. 21: 420-427, 2011. [PubMed: 21514828] [Full Text: https://doi.org/10.1016/j.nmd.2011.03.006]

  16. Ducreux, S., Zorzato, F., Muller, C., Sewry, C., Muntoni, F., Quinlivan, R., Restagno, G., Girard, T., Treves, S. Effect of ryanodine receptor mutations on interleukin-6 release and intracellular calcium homeostasis in human myotubes from malignant hyperthermia-susceptible individuals and patients affected by central core disease. J. Biol. Chem. 279: 43838-43846, 2004. [PubMed: 15299003] [Full Text: https://doi.org/10.1074/jbc.M403612200]

  17. Durham, W. J., Aracena-Parks, P., Long, C., Rossi, A. E., Goonasekera, S. A., Boncompagni, S., Galvan, D. L., Gilman, C. P., Baker, M. R., Shirokova, N., Protasi, F., Dirksen, R., Hamilton, S. L. RyR1 S-nitrosylation underlies environmental heat stroke and sudden death in Y522S RyR1 knockin mice. Cell 133: 53-65, 2008. [PubMed: 18394989] [Full Text: https://doi.org/10.1016/j.cell.2008.02.042]

  18. Efremov, R. G., Leitner, A., Aebersold, R., Raunser, S. Architecture and conformational switch mechanism of the ryanodine receptor. Nature 517: 39-43, 2015. [PubMed: 25470059] [Full Text: https://doi.org/10.1038/nature13916]

  19. Elbaz, M., Ruiz, A., Bachmann, C., Eckhardt, J., Pelczar, P., Venturi, E., Lindsay, C., Wilson, A. D., Alhussni, A., Humberstone, T., Pietrangelo, L., Boncompagni, S., Sitsapesan, R., Treves, S., Zorzato, F. Quantitative RyR1 reduction and loss of calcium sensitivity of RyR1Q1970fsX16+A4329D cause cores and loss of muscle strength. Hum. Molec. Genet. 28: 2987-2999, 2019. [PubMed: 31044239] [Full Text: https://doi.org/10.1093/hmg/ddz092]

  20. Elbaz, M., Ruiz, A., Eckhardt, J., Pelczar, O., Muntoni, F. Boncompagni, S., Treves, S., Zorzato, F. Quantitative reduction of RyR1 protein caused by a single-allele frameshift mutation in RYR1 ex36 impairs the strength of adult skeletal muscle fibres. Hum. Molec. Genet. 28: 1872-1884, 2019. [PubMed: 30689883] [Full Text: https://doi.org/10.1093/hmg/ddz025]

  21. Eu, J. P., Sun, J., Xu, L., Stamler, J. S., Meissner, G. The skeletal muscle calcium release channel: coupled O2 sensor and NO signaling functions. Cell 102: 499-509, 2000. [PubMed: 10966111] [Full Text: https://doi.org/10.1016/s0092-8674(00)00054-4]

  22. Fagerlund, T. H., Islander, G., Ranklev-Twetman, E., Berg, K. Recombination between the postulated CCD/MHE/MHS locus and RYR1 gene markers. Clin. Genet. 50: 455-458, 1996. [PubMed: 9147872] [Full Text: https://doi.org/10.1111/j.1399-0004.1996.tb02711.x]

  23. Fagerlund, T. H., Islander, G., Twetman, E. R., Berg, K. A search for three known RYR1 gene mutations in 41 Swedish families with predisposition to malignant hyperthermia. Clin. Genet. 48: 12-16, 1995. [PubMed: 7586638] [Full Text: https://doi.org/10.1111/j.1399-0004.1995.tb04047.x]

  24. Fagerlund, T. H., Ording, H., Bendixen, D., Islander, G., Ranklev Twetman, E., Berg, K. Discordance between malignant hyperthermia susceptibility and RYR1 mutation C1840T in two Scandinavian MH families exhibiting this mutation. Clin. Genet. 52: 416-421, 1997. [PubMed: 9520251] [Full Text: https://doi.org/10.1111/j.1399-0004.1997.tb02561.x]

  25. Fagerlund, T., Islander, G., Ranklev, E., Harbitz, I., Hauge, J. G., Mokleby, E., Berg, K. Genetic recombination between malignant hyperthermia and calcium release channel in skeletal muscle. Clin. Genet. 41: 270-272, 1992. [PubMed: 1318804]

  26. Fagerlund, T., Ording, H., Bendixen, D., Berg, K. Search for three known mutations in the RYR gene in 48 Danish families with malignant hyperthermia. Clin. Genet. 46: 401-404, 1994. [PubMed: 7889656] [Full Text: https://doi.org/10.1111/j.1399-0004.1994.tb04406.x]

  27. Fagerlund, T., Ording, H., Bendixen, D., Islander, G., Ranklev-Twetman, E., Berg, K. RYR1 mutation G1021A (gly341-to-arg) is not frequent in Danish and Swedish families with malignant hyperthermia susceptibility. Clin. Genet. 49: 186-188, 1996. [PubMed: 8828983] [Full Text: https://doi.org/10.1111/j.1399-0004.1996.tb03284.x]

  28. Ferreiro, A., Monnier, N., Romero, N. B., Leroy, J.-P., Bonnemann, C., Haenggeli, C.-A., Straub, V., Voss, W. D., Nivoche, Y., Jungbluth, H., Lemainque, A., Voit, T., Lunardi, J., Fardeau, M., Guicheney, P. A recessive form of central core disease, transiently presenting as multi-minicore disease, is associated with a homozygous mutation in the ryanodine receptor type 1 gene. Ann. Neurol. 51: 750-759, 2002. [PubMed: 12112081] [Full Text: https://doi.org/10.1002/ana.10231]

  29. Fujii, J., Otsu, K., Zorzato, F., de Leon, S., Khanna, V. K., Weiler, J. E., O'Brien, P. J., MacLennan, D. H. Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. Science 253: 448-451, 1991. [PubMed: 1862346] [Full Text: https://doi.org/10.1126/science.1862346]

  30. Gillard, E. F., Otsu, K., Fujii, J., Duff, C., de Leon, S., Khanna, V. K., Britt, B. A., Worton, R. G., MacLennan, D. H. Polymorphisms and deduced amino acid substitutions in the coding sequence of the ryanodine receptor (RYR1) gene in individuals with malignant hyperthermia. Genomics 13: 1247-1254, 1992. [PubMed: 1354642] [Full Text: https://doi.org/10.1016/0888-7543(92)90042-q]

  31. Gillard, E. F., Otsu, K., Fujii, J., Khanna, V. K., de Leon, S., Derdemezi, J., Britt, B. A., Duff, C. L., Worton, R. G., MacLennan, D. H. A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia. Genomics 11: 751-755, 1991. [PubMed: 1774074] [Full Text: https://doi.org/10.1016/0888-7543(91)90084-r]

  32. Girard, T., Urwyler, A., Censier, K., Mueller, C. R., Zorzato, F., Treves, S. Genotype-phenotype comparison of the Swiss malignant hyperthermia population. Hum. Mutat. 18: 357-358, 2001. [PubMed: 11668625] [Full Text: https://doi.org/10.1002/humu.1203]

  33. Guis, S., Figarella-Branger, D., Monnier, N., Bendahan, D., Kozak-Ribbens, G., Mattei, J.-P., Lunardi, J., Cozzone, P. J., Pellissier, J.-F. Multiminicore disease in a family susceptible to malignant hyperthermia: histology, in vitro contracture tests, and genetic characterization. Arch. Neurol. 61: 106-113, 2004. [PubMed: 14732627] [Full Text: https://doi.org/10.1001/archneur.61.1.106]

  34. Hall-Curran, J. L., Stewart, A. D., Ball, S. P., Halsall, J. P., Hopkins, P. M., Ellis, F. R. No C1840 to T mutation in RYR1 in malignant hyperthermia. (Letter) Hum. Mutat. 2: 330, 1993. [PubMed: 8401544] [Full Text: https://doi.org/10.1002/humu.1380020418]

  35. Harbitz, I., Chowdhary, B., Thomsen, P. D., Davies, W., Kaufmann, U., Kran, S., Gustavsson, I., Christensen, K., Hauge, J. G. Assignment of the porcine calcium release channel gene, a candidate for the malignant hyperthermia locus, to the 6p11-q21 segment of chromosome 6. Genomics 8: 243-248, 1990. [PubMed: 2174405] [Full Text: https://doi.org/10.1016/0888-7543(90)90278-3]

  36. Harbitz, I., Kristensen, T., Bosnes, M., Kran, S., Davies, W. DNA sequence of the skeletal muscle calcium release channel cDNA and verification of the arg615-to-cys615 mutation, associated with porcine malignant hyperthermia, in Norwegian Landrace pigs. Animal Genet. 23: 395-402, 1992. [PubMed: 1329581] [Full Text: https://doi.org/10.1111/j.1365-2052.1992.tb02157.x]

  37. Johnston, J. J., Dirksen, R. T., Girard, T., Gonsalves, S. G., Hopkins, P. M., Riazi, S., Saddic, L. A., Sambuughin, N., Saxena, R., Stowell, K., Weber, J., Rosenberg, H., Biesecker, L. G. Variant curation expert panel recommendations for RYR1 pathogenicity classifications in malignant hyperthermia susceptibility. Genet. Med. 23: 1288-1295, 2021. [PubMed: 33767344] [Full Text: https://doi.org/10.1038/s41436-021-01125-w]

  38. Joseph, M. R., Theroux, M. C., Mooney, J. J., Falitz, S., Brandom, B. W., Byler, D. L. Intraoperative presentation of malignant hyperthermia (confirmed by RYR1 gene mutation, c.7522C-T; p.R2508C) leads to diagnosis of King-Denborough syndrome in a child with hypotonia and dysmorphic features: a case report. A. A. Case Rep. 8: 55-57, 2017. [PubMed: 27918309] [Full Text: https://doi.org/10.1213/XAA.0000000000000421]

  39. Jungbluth, H., Muller, C. R., Halliger-Keller, B., Brockington, M., Brown, S. C., Feng, L., Chattopadhyay, A., Mercuri, E., Manzur, A. Y., Ferreiro, A., Laing, N. G., Davis, M. R., Roper, H. P., Dubowitz, V., Bydder, G., Sewry, C. A., Muntoni, F. Autosomal recessive inheritance of RYR1 mutations in a congenital myopathy with cores. Neurology 59: 284-287, 2002. [PubMed: 12136074] [Full Text: https://doi.org/10.1212/wnl.59.2.284]

  40. Jungbluth, H., Zhou, H., Hartley, L., Halliger-Keller, B., Messina, S., Longman, C., Brockington, M., Robb, S. A., Straub, V., Voit, T., Swash, M., Ferreiro, A., Bydder, G., Sewry, C. A., Muller, C., Muntoni, F. Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene. Neurology 65: 1930-1935, 2005. [PubMed: 16380615] [Full Text: https://doi.org/10.1212/01.wnl.0000188870.37076.f2]

  41. Keating, K. E., Quane, K. A., Manning, B. M., Lehane, M., Hartung, E., Censier, K., Urwyler, A., Klausnitzer, M., Muller, C. R., Heffron, J. J. A., McCarthy, T. V. Detection of a novel RYR1 mutation in four malignant hyperthermia pedigrees. Hum. Molec. Genet. 3: 1855-1858, 1994. [PubMed: 7849712] [Full Text: https://doi.org/10.1093/hmg/3.10.1855]

  42. Klein, A., Lillis, S., Munteanu, I., Scoto, M., Zhou, H., Quinlivan, R., Straub, V., Manzur, A. Y., Roper, H., Jeannet, P-Y., Rakowicz, W., Jones, D. H., and 20 others. Clinical and genetic findings in a large cohort of patients with ryanodine receptor 1 gene-associated myopathies. Hum. Mutat. 33: 981-988, 2012. Note: Erratum: Hum. Mutat. 33: 1310, 2012. [PubMed: 22473935] [Full Text: https://doi.org/10.1002/humu.22056]

  43. Kossugue, P. M., Paim, J. F., Navarro, M. M., Silva, H. C., Pavanello, R. C. M., Gurgel-Giannetti, J., Zatz, M., Vainzof, M. Central core disease due to recessive mutations in RYR1 gene: is it more common than described? Muscle Nerve 35: 670-674, 2007. [PubMed: 17226826] [Full Text: https://doi.org/10.1002/mus.20715]

  44. Levitt, R. C., Nouri, N., Jedlicka, A. E., McKusick, V. A., Marks, A. R., Shutack, J. G., Fletcher, J. E., Rosenberg, H., Meyers, D. A. Evidence for genetic heterogeneity in malignant hyperthermia susceptibility. Genomics 11: 543-547, 1991. [PubMed: 1774061] [Full Text: https://doi.org/10.1016/0888-7543(91)90061-i]

  45. Lyfenko, A. D., Goonasekera, S. A., Dirksen, R. T. Dynamic alterations in myoplasmic Ca(2+) in malignant hyperthermia and central core disease. Biochem. Biophys. Res. Commun. 322: 1256-1266, 2004. [PubMed: 15336973] [Full Text: https://doi.org/10.1016/j.bbrc.2004.08.031]

  46. Lynch, P. J., Tong, J., Lehane, M., Mallet, A., Giblin, L., Heffron, J. J. A., Vaughan, P., Zafra, G., MacLennan, D. H., McCarthy, T. V. A mutation in the transmembrane/luminal domain of the ryanodine receptor is associated with abnormal Ca(2+) release channel function and severe central core disease. Proc. Nat. Acad. Sci. 96: 4164-4169, 1999. [PubMed: 10097181] [Full Text: https://doi.org/10.1073/pnas.96.7.4164]

  47. MacKenzie, A. E., Korneluk, R. G., Zorzato, F., Fujii, J., Phillips, M., Iles, D., Wieringa, B., Leblond, S., Bailly, J., Willard, H. F., Duff, C., Worton, R. G., MacLennan, D. H. The human ryanodine receptor gene: its mapping to 19q13.1, placement in a chromosome 19 linkage group, and exclusion as the gene causing myotonic dystrophy. Am. J. Hum. Genet. 46: 1082-1089, 1990. [PubMed: 1971150]

  48. MacLennan, D. H., Zorzato, F., Fujii, J., Otsu, K., Phillips, M., Lai, F. A., Meissner, G., Green, N. M., Willard, H. F., Britt, B. A., Worton, R. G., Korneluk, R. G. Cloning and localization of the human calcium release channel (ryanodine receptor) gene to the proximal long arm (cen-q13.2) of human chromosome 19. (Abstract) Am. J. Hum. Genet. 45 (suppl.): A205 only, 1989.

  49. Manning, B. M., Quane, K. A., Lynch, P. J., Urwyler, A., Tegazzin, V., Krivosic-Horber, R., Censier, K., Comi, G., Adnet, P., Wolz, W., Lunardi, J., Muller, C. R., McCarthy, T. V. Novel mutations at a CpG dinucleotide in the ryanodine receptor in malignant hyperthermia. Hum. Mutat. 11: 45-50, 1998. [PubMed: 9450902] [Full Text: https://doi.org/10.1002/(SICI)1098-1004(1998)11:1<45::AID-HUMU7>3.0.CO;2-K]

  50. Manning, B. M., Quane, K. A., Ording, H., Urwyler, A., Tegazzin, V., Lehane, M., O'Halloran, J., Hartung, E., Giblin, L. M., Lynch, P. J., Vaughan, P., Censier, K., Bendixen, D., Comi, G., Heytens, L., Monsieurs, K., Fagerlund, T., Wolz, W., Heffron, J. J. A., Muller, C. R., McCarthy, T. V. Identification of novel mutations in the ryanodine-receptor gene (RYR1) in malignant hyperthermia: genotype-phenotype correlation. Am. J. Hum. Genet. 62: 599-609, 1998. [PubMed: 9497245] [Full Text: https://doi.org/10.1086/301748]

  51. Mattei, M. G., Giannini, G., Moscatelli, F., Sorrentino, V. Chromosomal localization of murine ryanodine receptor genes RYR1, RYR2, and RYR3 by in situ hybridization. Genomics 22: 202-204, 1994. [PubMed: 7959768] [Full Text: https://doi.org/10.1006/geno.1994.1362]

  52. McCarthy, T. V., Quane, K. A., Lynch, P. J. Ryanodine receptor mutations in malignant hyperthermia and central core disease. Hum. Mutat. 15: 410-417, 2000. [PubMed: 10790202] [Full Text: https://doi.org/10.1002/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D]

  53. McKie, A. B., Alsaedi, A., Vogt, J., Stuurman, K. E., Weiss, M. M., Shakeel, H., Tee, L., Morgan, N. V., Nikkels, P. G. J., van Haaften, G., Park, S.-M., van der Smagt, J. J., Bugiani, M., Maher, E. R. Germline mutations in RYR1 are associated with foetal akinesia deformation sequence/lethal multiple pterygium syndrome. Acta Neuropath. Commun. 2: 148, 2014. Note: Electronic Article. [PubMed: 25476234] [Full Text: https://doi.org/10.1186/s40478-014-0148-0]

  54. Monnier, N., Ferreiro, A., Marty, I., Labarre-Vila, A., Mezin, P., Lunardi, J. A homozygous splicing mutation causing a depletion of skeletal muscle RYR1 is associated with multi-minicore disease congenital myopathy with ophthalmoplegia. Hum. Molec. Genet. 12: 1171-1178, 2003. [PubMed: 12719381] [Full Text: https://doi.org/10.1093/hmg/ddg121]

  55. Monnier, N., Kozak-Ribbens, G., Krivosic-Horber, R., Nivoche, Y., Qi, D., Kraev, N., Loke, J., Sharma, P., Tegazzin, V., Figarella-Branger, D., Romero, N., Mezin, P., Bendahan, D., Payen, J.-F., Depret, T., Maclennan, D. H., Lunardi, J. Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibility. Hum. Mutat. 26: 413-425, 2005. [PubMed: 16163667] [Full Text: https://doi.org/10.1002/humu.20231]

  56. Monnier, N., Marty, I., Faure, J., Castiglioni, C., Desnuelle, C., Sacconi, S., Estournet, B., Ferreiro, A., Romero, N., Laquerriere, A., Lazaro, L., Martin, J.-J., Morava, E., Rossi, A., Van der Kooi, A., de Visser, M., Verschuuren, C., Lunardi, J. Null mutations causing depletion of the type 1 ryanodine receptor (RYR1) are commonly associated with recessive structural congenital myopathies with cores. Hum. Mutat. 29: 670-678, 2008. [PubMed: 18253926] [Full Text: https://doi.org/10.1002/humu.20696]

  57. Monnier, N., Romero, N. B., Lerale, J., Landrieu, P., Nivoche, Y., Fardeau, M., Lunardi, J. Familial and sporadic forms of central core disease are associated with mutations in the C-terminal domain of the skeletal muscle ryanodine receptor. Hum. Molec. Genet. 10: 2581-2592, 2001. [PubMed: 11709545] [Full Text: https://doi.org/10.1093/hmg/10.22.2581]

  58. Monnier, N., Romero, N. B., Lerale, J., Nivoche, Y., Qi, D., MacLennan, D. H., Fardeau, M., Lunardi, J. An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor. Hum. Molec. Genet. 9: 2599-2608, 2000. [PubMed: 11063719] [Full Text: https://doi.org/10.1093/hmg/9.18.2599]

  59. Monsieurs, K. G., Van Broeckhoven, C., Martin, J.-J., Van Hoof, V. O., Heytens, L. Gly341arg mutation indicating malignant hyperthermia susceptibility: specific cause of chronically elevated serum creatine kinase activity. J. Neurol. Sci. 154: 62-65, 1998. [PubMed: 9543323] [Full Text: https://doi.org/10.1016/s0022-510x(97)00215-3]

  60. O'Brien, R. O., Taske, N. L., Hansbro, P. M., Matthaei, K. I., Hogan, S. P., Denborough, M. A., Foster, P. S. Exclusion of defects in the skeletal muscle specific regions of the DHPR alpha-1 subunit as frequent causes of malignant hyperthermia. J. Med. Genet. 32: 913-914, 1995. [PubMed: 8592342] [Full Text: https://doi.org/10.1136/jmg.32.11.913]

  61. Otsu, K., Khanna, V. K., Archibald, A. L., MacLennan, D. H. Cosegregation of porcine malignant hyperthermia and a probable causal mutation in the skeletal muscle ryanodine receptor gene in backcross families. Genomics 11: 744-750, 1991. [PubMed: 1774073] [Full Text: https://doi.org/10.1016/0888-7543(91)90083-q]

  62. Otsu, K., Nishida, K., Kimura, Y., Kuzuya, T., Hori, M., Kamada, T., Tada, M. The point mutation arg615-to-cys in the Ca(2+) release channel of skeletal sarcoplasmic reticulum is responsible for hypersensitivity to caffeine and halothane in malignant hyperthermia. J. Biol. Chem. 269: 9413-9415, 1994. [PubMed: 7511586]

  63. Otsu, K., Phillips, M. S., Khanna, V. K., de Leon, S., MacLennan, D. H. Refinement of diagnostic assays for a probable causal mutation for porcine and human malignant hyperthermia. Genomics 13: 835-837, 1992. [PubMed: 1639409] [Full Text: https://doi.org/10.1016/0888-7543(92)90163-m]

  64. Phillips, M. S., Fujii, J., Khanna, V. K., DeLeon, S., Yokobata, K., De Jong, P. J., MacLennan, D. H. The structural organization of the human skeletal muscle ryanodine receptor (RYR1) gene. Genomics 34: 24-41, 1996. [PubMed: 8661021] [Full Text: https://doi.org/10.1006/geno.1996.0238]

  65. Quane, K. A., Healy, J. M. S., Keating, K. E., Manning, B. M., Couch, F. J., Palmucci, L. M., Doriguzzi, C., Fagerlund, T. H., Berg, K., Ording, H., Bendixen, D., Mortier, W., Linz, U., Muller, C. R., McCarthy, T. V. Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia. Nature Genet. 5: 51-55, 1993. [PubMed: 8220423] [Full Text: https://doi.org/10.1038/ng0993-51]

  66. Quane, K. A., Keating, K. E., Healy, J. M. S., Manning, B. M., Krivosic-Horber, R., Krivosic, I., Monnier, N., Lunardi, J., McCarthy, T. V. Mutation screening of the RYR1 gene in malignant hyperthermia: detection of a novel tyr to ser mutation in a pedigree with associated central cores. Genomics 23: 236-239, 1994. [PubMed: 7829078] [Full Text: https://doi.org/10.1006/geno.1994.1483]

  67. Quane, K. A., Keating, K. E., Manning, B. M., Healy, J. M. S., Monsieurs, K., Heffron, J. J. A., Lehane, M., Heytens, L., Krivosic-Horber, R., Adnet, P., Ellis, F. R., Monnier, N., Lunardi, J., McCarthy, T. V. Detection of a novel common mutation in the ryanodine receptor gene in malignant hyperthermia: implications for diagnosis and heterogeneity studies. Hum. Molec. Genet. 3: 471-476, 1994. [PubMed: 8012359] [Full Text: https://doi.org/10.1093/hmg/3.3.471]

  68. Quinlivan, R. M., Muller, C. R., Davis, M., Laing, N. G., Evans, G. A., Dwyer, J., Dove, J., Roberts, A. P., Sewry, C. A. Central core disease: clinical, pathological, and genetic features. Arch. Dis. Child. 88: 1051-1055, 2003. [PubMed: 14670767] [Full Text: https://doi.org/10.1136/adc.88.12.1051]

  69. Richter, M., Schleithoff, L., Deufel, T., Lehmann-Horn, F., Herrmann-Frank, A. Functional characterization of a distinct ryanodine receptor mutation in human malignant hyperthermia-susceptible muscle. J. Biol. Chem. 272: 5256-5260, 1997. [PubMed: 9030597] [Full Text: https://doi.org/10.1074/jbc.272.8.5256]

  70. Robinson, R., Carpenter, D., Shaw, M.-A., Halsall, J., Hopkins, P. Mutations in RYR1 in malignant hyperthermia and central core disease. Hum. Mutat. 27: 977-989, 2006. [PubMed: 16917943] [Full Text: https://doi.org/10.1002/humu.20356]

  71. Robinson, R. L., Brooks, C., Brown, S. L., Ellis, F. R., Halsall, P. J., Quinnell, R. J., Shaw, M.-A., Hopkins, P. M. RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes. Hum. Mutat. 20: 88-97, 2002. [PubMed: 12124989] [Full Text: https://doi.org/10.1002/humu.10098]

  72. Sambuughin, N., McWilliams, S., de Bantel, A., Sivakumar, K., Nelson, T. E. Single-amino-acid deletion in the RYR1 gene, associated with malignant hyperthermia susceptibility and unusual contraction phenotype. Am. J. Hum. Genet. 69: 204-208, 2001. [PubMed: 11389482] [Full Text: https://doi.org/10.1086/321270]

  73. Sato, I., Wu, S., Ibarra, M. C. A., Hayashi, Y. K., Fujita, H., Tojo, M., Oh, S. J., Nonaka, I., Noguchi, S., Nishino, I. Congenital neuromuscular disease with uniform type 1 fiber and RYR1 mutation. Neurology 70: 114-122, 2008. [PubMed: 17538032] [Full Text: https://doi.org/10.1212/01.wnl.0000269792.63927.86]

  74. Scacheri, P. C., Hoffman, E. P., Fratkin, J. D., Semino-Mora, C., Senchak, A., Davis, M. R., Laing, N. G., Vedanarayanan, V., Subramony, S. H. A novel ryanodine receptor gene mutation causing both cores and rods in congenital myopathy. Neurology 55: 1689-1696, 2000. [PubMed: 11113224] [Full Text: https://doi.org/10.1212/wnl.55.11.1689]

  75. Shuaib, A., Paasuke, R. T., Brownell, K. W. Central core disease: clinical features in 13 patients. Medicine 66: 389-396, 1987. [PubMed: 3626847]

  76. Stewart, S. L., Rosenberg, H., Fletcher, J. E. Failure to identify the ryanodine receptor G1021A mutation in a large North American population with malignant hyperthermia. Clin. Genet. 54: 358-361, 1998. [PubMed: 9831351] [Full Text: https://doi.org/10.1034/j.1399-0004.1998.5440417.x]

  77. Swash, M., Schwartz, M. S. Familial multicore disease with focal loss of cross-striations and ophthalmoplegia. J. Neurol. Sci. 52: 1-10, 1981. [PubMed: 7299413] [Full Text: https://doi.org/10.1016/0022-510x(81)90129-5]

  78. Takeshima, H., Iino, M., Takekura, H., Nishi, M., Kuno, J., Minowa, O., Takano, H., Noda, T. Excitation-contraction uncoupling and muscular degeneration in mice lacking functional skeletal muscle ryanodine-receptor gene. Nature 369: 556-559, 1994. [PubMed: 7515481] [Full Text: https://doi.org/10.1038/369556a0]

  79. Takeshima, H., Yamazawa, T., Ikemoto, T., Takekura, H., Nishi, M., Noda, T., Iino, M. Ca(2+)-induced Ca(2+) release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. EMBO J. 14: 2999-3006, 1995. [PubMed: 7621815] [Full Text: https://doi.org/10.1002/j.1460-2075.1995.tb07302.x]

  80. Tegazzin, V., Accorsi, A., Gritti, G., Arcelli, L., Di Giovanni, A. MH fulminant reaction after eight anaesthetics: a case report. Minerva Anestesiol. 60: 217-219, 1994.

  81. Tilgen, N., Zorzato, F., Halliger-Keller, B., Muntoni, F., Sewry, C., Palumucci, L. M., Schneider, C., Hauser, E., Lehmann-Horn, F., Muller, C. R., Treves, S. Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis. Hum. Molec. Genet. 10: 2879-2887, 2001. [PubMed: 11741831] [Full Text: https://doi.org/10.1093/hmg/10.25.2879]

  82. Tobin, J. R., Jason, D. R., Challa, V. R., Nelson, T. E., Sambuughin, N. Malignant hyperthermia and apparent heat stroke. (Letter) JAMA 286: 168-169, 2001. [PubMed: 11448278] [Full Text: https://doi.org/10.1001/jama.286.2.168]

  83. Tojo, M., Ozawa, M., Nonaka, I. Central core disease and congenital neuromuscular disease with uniform type 1 fibers in one family. Brain Dev. 22: 262-264, 2000. [PubMed: 10838116] [Full Text: https://doi.org/10.1016/s0387-7604(00)00108-x]

  84. Trask, B., Fertitta, A., Christensen, M., Youngblom, J., Bergmann, A., Copeland, A., de Jong, P., Mohrenweiser, H., Olsen, A., Carrano, A., Tynan, K. Fluorescence in situ hybridization mapping of human chromosome 19: cytogenetic band location of 540 cosmids and 70 genes or DNA markers. Genomics 15: 133-145, 1993. [PubMed: 8432525] [Full Text: https://doi.org/10.1006/geno.1993.1021]

  85. Tung, C.-C., Lobo, P. A., Kimlicka, L., Van Petegem, F. The amino-terminal disease hotspot of ryanodine receptors forms a cytoplasmic vestibule. Nature 468: 585-588, 2010. [PubMed: 21048710] [Full Text: https://doi.org/10.1038/nature09471]

  86. Wang, S.-Q., Song, L.-S., Lakatta, E. G., Cheng, H. Ca(2+) signalling between single L-type Ca(2+) channels and ryanodine receptors in heart cells. Nature 410: 592-596, 2001. [PubMed: 11279498] [Full Text: https://doi.org/10.1038/35069083]

  87. Wehner, M., Rueffert, H., Koenig, F., Neuhaus, J., Olthoff, D. Increased sensitivity to 4-chloro-m-cresol and caffeine in primary myotubes from malignant hyperthermia susceptible individuals carrying the ryanodine receptor 1 thr2206met (C6617T) mutation. Clin. Genet. 62: 135-146, 2002. [PubMed: 12220451] [Full Text: https://doi.org/10.1034/j.1399-0004.2002.620206.x]

  88. Wilmshurst, J. M., Lillis, S., Zhou, H., Pillay, K., Henderson, H., Kress, W., Muller, C. R., Ndondo, A., Cloke, V., Cullup, T., Bertini, E., Boennemann, C., and 10 others. RYR1 mutations are a common cause of congenital myopathies with central nuclei. Ann. Neurol. 68: 717-726, 2010. [PubMed: 20839240] [Full Text: https://doi.org/10.1002/ana.22119]

  89. Wu, S., Ibarra M, C. A., Malicdan, M. C. V., Murayama, K., Ichihara, Y., Kikuchi, H., Nonaka, I., Noguchi, S., Hayashi, Y. K., Nishino, I. Central core disease is due to RYR1 mutations in more than 90% of patients. Brain 129: 1470-1480, 2006. [PubMed: 16621918] [Full Text: https://doi.org/10.1093/brain/awl077]

  90. Yan, Z., Bai, X., Yan, C., Wu, J., Li, Z., Xie, T., Peng, W., Yin, C., Li, X., Scheres, S. H. W., Shi, Y., Yan, N. Structure of the rabbit ryanodine receptor RyR1 at near-atomic resolution. Nature 517: 50-55, 2015. [PubMed: 25517095] [Full Text: https://doi.org/10.1038/nature14063]

  91. Zalk, R., Clarke, O. B., des Georges, A., Grassucci, R. A., Reiken, S., Mancia, F., Hendrickson, W. A., Frank, J., Marks, A. R. Structure of a mammalian ryanodine receptor. Nature 517: 44-49, 2015. [PubMed: 25470061] [Full Text: https://doi.org/10.1038/nature13950]

  92. Zhang, Y., Chen, H. S., Khanna, V. K., De Leon, S., Phillips, M. S., Schappert, K., Britt, B. A., Brownell, A. K. W., MacLennan, D. H. A mutation in the human ryanodine receptor gene associated with central core disease. Nature Genet. 5: 46-50, 1993. [PubMed: 8220422] [Full Text: https://doi.org/10.1038/ng0993-46]

  93. Zhou, H., Brockington, M., Jungbluth, H., Monk, D., Stanier, P., Sewry, C. A., Moore, G. E., Muntoni, F. Epigenetic allele silencing unveils recessive RYR1 mutations in core myopathies. Am. J. Hum. Genet. 79: 859-868, 2006. [PubMed: 17033962] [Full Text: https://doi.org/10.1086/508500]

  94. Zorzato, F., Fujii, J., Otsu, K., Phillips, M., Green, N. M., Lai, F. A., Meissner, G., MacLennan, D. H. Molecular cloning of cDNA encoding human and rabbit forms of the Ca(2+) release channel (ryanodine receptor) of skeletal muscle sarcoplasmic reticulum. J. Biol. Chem. 265: 2244-2256, 1990. [PubMed: 2298749]

  95. Zorzato, F., Yamaguchi, N., Xu, L., Meissner, G., Muller, C. R., Pouliquin, P., Muntoni, F., Sewry, C., Girard, T., Treves, S. Clinical and functional effects of a deletion in a COOH-terminal lumenal loop of the skeletal muscle ryanodine receptor. Hum. Molec. Genet. 12: 379-388, 2003. [PubMed: 12566385] [Full Text: https://doi.org/10.1093/hmg/ddg032]